Filing metadata

Accession number
0001062993-25-008341
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
May 01, 2025
Reporting period
Apr 30, 2025
Description
Insider transaction

Explore SEC Filings Hub